Report Content
Chapter 1 Methodology & Scope
1.1 Market scope & definitions
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast parameters
1.5 Data validation
1.6 Data sources
1.6.1 Primary
1.6.2 Secondary
1.6.2.1 Paid sources
1.6.2.2 Public sources
Chapter 2 Executive Summary
2.1 Industry 3600 synopsis
Chapter 3 Industry Insights
3.1 Industry ecosystem analysis
3.2 Industry impact forces
3.2.1 Growth drivers
3.2.1.1 Rising incidence of pneumonia and legionella related illnesses
3.2.1.2 Rapid advancements in legionella testing
3.2.1.3 Stringent regulations for regular water testing
3.2.2 Industry pitfalls & challenges
3.2.2.1 High costs associated with testing procedures
3.2.2.2 Issues in sensitivity of diagnostic tests
3.3 Growth potential analysis
3.4 Technological landscape
3.5 Regulatory landscape
3.6 Porter’s analysis
3.6.1 Supplier power
3.6.2 Buyer power
3.6.3 Threat of new entrants
3.6.4 Threat of substitutes
3.6.5 Industry rivalry
3.7 PESTEL analysis
Chapter 4 Competitive Landscape, 2023
4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix
Chapter 5 Market Estimates and Forecast, By Test Type, 2018 – 2032 ($ Mn)
5.1 Key trends
5.2 Culture methods
5.3 Urinary antigen test (UAT)
5.4 Serology
5.5 Direct fluorescent antibody test (DFA)
5.6 Polymerase chain reaction (PCR) testing
5.7 Other test types
Chapter 6 Market Estimates and Forecast, By Application, 2018 – 2032 ($ Mn)
6.1 Key trends
6.2 Water testing
6.2.1 Microbial culture
6.2.2 DFA stain
6.2.3 PCR
6.3 Invitro diagnostics (IVD) testing
6.3.1 Blood culture and sputum tests
6.3.2 Urinary antigen tests
6.3.3 DFA stain
6.3.4 PCR
6.4 Other applications
Chapter 7 Market Estimates and Forecast, By End-Use, 2018 – 2032 ($ Mn)
7.1 Key trends
7.2 Hospital and clinics
7.3 Water treatment plants
7.4 Diagnostic laboratories
7.5 Other end-users
Chapter 8 Market Estimates and Forecast, By Region, 2018 – 2032 ($ Mn)
8.1 Key trends
8.2 North America
8.2.1 U.S.
8.2.2 Canada
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 France
8.3.4 Spain
8.3.5 Italy
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 South Korea
8.4.6 Rest of Asia Pacific
8.5 Latin America
8.5.1 Brazil
8.5.2 Argentina
8.5.3 Mexico
8.5.4 Rest of Latin America
8.6 Middle East and Africa
8.6.1 South Africa
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Rest of Middle East and Africa
Chapter 9 Company Profiles
9.1 Abbott Laboratories
9.2 Becton, Dickinson & Company
9.3 Biomerieux
9.4 Bio-Rad Laboratories Inc.
9.5 Danaher Corporation
9.6 IDEXX Laboratories Inc
9.7 Merck KGaA
9.8 Pro-lab Diagnostics Inc.
9.9 QIAGEN N.V.
9.10 Thermo Fisher Scientific Inc.
